<DOC>
	<DOCNO>NCT01549795</DOCNO>
	<brief_summary>Single-arm pilot clinical trial . Patients non operable CC associate PSC subject liver transplantation neoadjuvant multimodal therapy protocol . Cholangiocarcinoma ( CC ) account 3 % gastrointestinal cancer ; frequent patient primary sclerosing cholangitis ( PSC ) , carry 8 % -12 % risk develop type neoplasm . Only minority patient suitable resection partly anatomic position tumor ( often arise bile duct bifurcation ) partly frequently coexist liver disease . In fact , CC currently consider major contraindication liver transplantation ( OLT ) majority center , give 5-year survival rate 0 % -35 % . New strategy develop treatment kind cancer arise PSC . The Nebraska University group show 1 3 year survival 55 45 % combine neoadjuvant intra bile duct barchytherapy 5-FU base chemotherapy liver transplantation . University Pittsburg propose also neoadjuvant protocol prior liver transplantation base systemic chemotherapy external radiotherapy report 53 % 5 year survival . More convincing result come Mayo Clinic . An accurate selection patient proper neoadjuvant multimodal therapy ( chemotherapy , external radiotherapy intraluminal bile duct brachytherapy ) lead 80 % 5 year survival liver transplantation .</brief_summary>
	<brief_title>Liver Transplantation Hilar Cholangiocarcinoma Association With Neoadjuvant Radio- Chemo-therapy</brief_title>
	<detailed_description />
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Cholangitis</mesh_term>
	<mesh_term>Cholangitis , Sclerosing</mesh_term>
	<mesh_term>Klatskin Tumor</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Older 18 year Male female Diagnosis Cholangiocarcinoma use : PTBD biopsy Brushing cytology Ca 199 &gt; 100mg/ml and/or liver mass CT MRI malignant stenosis apperance Cholangiography , Non resectable tumour araising cystic duct Absence intra extra hepatic metastasis ECOG score ( Eastern Cooperative Oncology Group ) 0 ASA score ( American Society Anesthesiologists ) â‰¤ 3 Ability understand willingness sign write informed consent form ( ICF ) Intrahepatic Cholangiocarcinoma Non control infection Previous radio chemotherapy Previsous bile duct resection attempt resection Intra and/or extrahepatic metastasis Preivious malignant neoplasm ( within 5 year ) Execution trans peritoneal biopsy Tumour diameter 3 cm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Liver transplantation</keyword>
	<keyword>Neoadjuvant radio- chemo-therapy</keyword>
</DOC>